1992 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Core outcome set measurement for future clinical trials in acute myeloid leukemia: The HARMONY study protocol using a multi-stakeholder consensus-based Delphi process and a final consensus meeting

Lang, K. M., Harrison, K. L., Williamson, P. R., Huntly, B. J. P., Ossenkoppele, G., Geissler, J., Bereczky, T., Hernández-Rivas, J. M., Chevrou-Séverac, H., Goodbody, R., Schulze-Rath, R. & Bullinger, L., 27 May 2020, In : Trials. 21, 1, 437.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Correction: Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS (Leukemia, (2020), 34, 7, (1751-1759), 10.1038/s41375-020-0725-0)

Ossenkoppele, G. J., Breems, D. A., Stuessi, G., van Norden, Y., Bargetzi, M., Biemond, B. J., A von dem Borne, P., Chalandon, Y., Cloos, J., Deeren, D., Fehr, M., Gjertsen, B. T., Graux, C., Huls, G., Janssen, J. J. J. W., Jaspers, A., Jongen-Lavrencic, M., de Jongh, E., Klein, S. K., Van der Klift, M. & 69 others, Van Marwijk Kooy, M., Maertens, J., Michaux, L., van der Poel, M. W. M., Van Rhenen, A., Tick, L., Valk, P., Vekemans, M. C., van der Velden, W. J. F. M., de Weerdt, O., Pabst, T., Manz, M., Löwenberg, B., Breems, D. A., Havelange, Vekemans, M. C., Moors, I., van Obberg, F., Maertens, J. A., Hodossy, B., Vansteenweghen, S., Lammertijn, L., Deeren, D., Graux, C., Sonet, A., Triffet, A., Gjertsen, B. T., Bargetzi, M., Passweg, J., Heim, D., Giovanni, S., Stuessi, G., Pabst, T., Betticher, D., Chalandon, Y., Spertini, O., Gregor, M., Hess, U., Fehr, M., Manz, M. G., Klein, S. K., Biemond, B. J., Ossenkoppele, G. J., van de Loosdrecht, A., Janssen, J. J. W. M., van Esser, J. W. J., Van der Klift, M., Brouwer, R. E., Van Lammeren-Venema, D., Levin, M. D., Tick, L. W., Legdeur, M. C. J. C., Huls, G., Vellenga, E., Hoogendoorn, M., Veelken, J. H., von dem Borne, P. A., Schouten, H. C., de Weerdt, O., van der Velden, W. J. F. M., Cornelissen, J., Jongen-Lavrencic, M., Wouters, B., Raaijmakers, H. G. M., Löwenberg, B., Kuball, J., Van Rhenen, A., Van Marwijk Kooy, M. & for the Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON) and Swiss Group for Clinical Cancer Research (SAKK), 1 Jan 2020, (Accepted/In press) In : Leukemia.

Research output: Contribution to journalComment/Letter to the editorAcademic

Open Access

EHA evaluation of the ESMO-Magnitude of Clinical Benefit Scale version 1.1 (ESMO-MCBS v1.1) for haematological malignancies

Kiesewetter, B., Cherny, N. I., Boissel, N., Cerisoli, F., Dafni, U., de Vries, E. G. E., Ghia, P., Gökbuget, N., González-Calle, V., Huntly, B., Jäger, U., Latino, N. J., Douillard, J-Y., Malcovati, L., Mateos, M-V., Ossenkoppele, G. J., Porkka, K., Raderer, M., Ribera, J-M., Scarfò, L. & 3 others, Wester, R., Zygoura, P. & Sonneveld, P., Jan 2020, In : ESMO OPEN. 5, 1, e000611.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS

Ossenkoppele, G. J., Breems, D. A., Stuessi, G., van Norden, Y., Bargetzi, M., Biemond, B. J., A von dem Borne, P., Chalandon, Y., Cloos, J., Deeren, D., Fehr, M., Gjertsen, B. T., Graux, C., Huls, G., Janssen, J. J. J. W., Jaspers, A., Jongen-Lavrencic, M., de Jongh, E., Klein, S. K., Van der Klift, M. & 14 others, Van Marwijk Kooy, M., Maertens, J., Micheaux, L., van der Poel, M. W. M., Van Rhenen, A., Tick, L., Valk, P., Vekemans, M. C., van der Velden, W. J. F. M., de Weerdt, O., Pabst, T., Manz, M., Löwenberg, B. & for the Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON) and Swiss Group for Clinical Cancer Research (SAKK), 1 Jan 2020, In : Leukemia. 34, 7, 9 p.

Research output: Contribution to journalArticleAcademicpeer-review

Phosphotyrosine-based phosphoproteomics for target identification and drug response prediction in AML cell lines

van Alphen, C., Cloos, J., Beekhof, R., Cucchi, DGJ., Piersma, SR., Knol, J. C., Henneman, AA., Pham, TV., van Meerloo, J., Ossenkoppele, GJ., Verheul, HMW., Janssen, JJWM. & Jimenez, CR., 26 Feb 2020, In : Molecular and Cellular Proteomics. 19, 5, 16 p.

Research output: Contribution to journalArticleAcademicpeer-review